Literature DB >> 24493975

Random sparse sampling strategy using stochastic simulation and estimation for a population pharmacokinetic study.

Xiao-Hui Huang1, Kun Wang2, Ji-Han Huang2, Ling Xu2, Lu-Jin Li2, Yu-Cheng Sheng2, Qing-Shan Zheng2.   

Abstract

The purpose of this study was to use the stochastic simulation and estimation method to evaluate the effects of sample size and the number of samples per individual on the model development and evaluation. The pharmacokinetic parameters and inter- and intra-individual variation were obtained from a population pharmacokinetic model of clinical trials of amlodipine. Stochastic simulation and estimation were performed to evaluate the efficiencies of different sparse sampling scenarios to estimate the compartment model. Simulated data were generated a 1000 times and three candidate models were used to fit the 1000 data sets. Fifty-five kinds of sparse sampling scenarios were investigated and compared. The results showed that, 60 samples with three points and 20 samples with five points are recommended, and the quantitative methodology of stochastic simulation and estimation is valuable for efficiently estimating the compartment model and can be used for other similar model development and evaluation approaches.

Entities:  

Keywords:  Amlodipine; Model estimation; Population pharmacokinetics; Sparse sampling

Year:  2013        PMID: 24493975      PMCID: PMC3909756          DOI: 10.1016/j.jsps.2013.01.010

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  10 in total

1.  Limited-sampling strategy models for estimating the area under the plasma concentration-time curve for amlodipine.

Authors:  G Suarez-Kurtz; F L Vicente; C G Ponte; V L Buy; C J Struchiner
Journal:  Eur J Clin Pharmacol       Date:  1999-11       Impact factor: 2.953

2.  Experimental design and efficient parameter estimation in population pharmacokinetics.

Authors:  M K al-Banna; A W Kelman; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

Review 3.  A pragmatic approach to the design of population pharmacokinetic studies.

Authors:  Amit Roy; Ene I Ette
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

4.  Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.

Authors:  Andrew C Hooker; Christine E Staatz; Mats O Karlsson
Journal:  Pharm Res       Date:  2007-07-06       Impact factor: 4.200

5.  Evaluation of population pharmacokinetics and exposure-response relationship with coadministration of amlodipine besylate and olmesartan medoxomil.

Authors:  Shashank Rohatagi; Timothy J Carrothers; Smita Kshirsagar; Tatiana Khariton; James Lee; Daniel Salazar
Journal:  J Clin Pharmacol       Date:  2008-05-19       Impact factor: 3.126

6.  Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies.

Authors:  L Aarons; L P Balant; F Mentre; P L Morselli; M Rowland; J L Steimer; S Vozeh
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

7.  The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily.

Authors:  J K Faulkner; D McGibney; L F Chasseaud; J L Perry; I W Taylor
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

8.  Experimental design and efficient parameter estimation in preclinical pharmacokinetic studies.

Authors:  E I Ette; C A Howie; A W Kelman; B Whiting
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

9.  Population pharmacokinetics of amlodipine in hypertensive children and adolescents.

Authors:  Joseph T Flynn; Milap C Nahata; John D Mahan; Ronald J Portman
Journal:  J Clin Pharmacol       Date:  2006-08       Impact factor: 3.126

10.  Prospective evaluation of a D-optimal designed population pharmacokinetic study.

Authors:  Bruce Green; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-04       Impact factor: 2.745

  10 in total
  2 in total

1.  Is One Sample Enough? β-Lactam Target Attainment and Penetration into Epithelial Lining Fluid Based on Multiple Bronchoalveolar Lavage Sampling Time Points in a Swine Pneumonia Model.

Authors:  Ana Motos; Joseph L Kuti; Gianluigi Li Bassi; Antoni Torres; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 2.  Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management.

Authors:  Rannissa Puspita Jayanti; Nguyen Phuoc Long; Nguyen Ky Phat; Yong-Soon Cho; Jae-Gook Shin
Journal:  Pharmaceutics       Date:  2022-05-05       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.